Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
10/2010
10/12/2010US7812019 Chromanylurea compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor and uses thereof
10/12/2010US7811681 Electron transport compound and organic light emitting device comprising the same
10/12/2010CA2533919C Therapeutic agent for chronic obstructive pulmonary disease and method for treating chronic obstructive pulmonary disease using the same
10/12/2010CA2478283C Process for trans-4-amino-1-cyclohexanecarboxylic acid derivatives
10/12/2010CA2455863C Tetrahydroquinoline derivatives as gamma secretase inhibitors
10/12/2010CA2407149C Melanin-concentrating hormone antagonist
10/12/2010CA2339761C Arylpiperazines and their use as metalloproteinase inhibiting agents (mmp)
10/07/2010WO2010114493A1 Lanthanide metal complexes useful in treating cancer
10/07/2010WO2010113498A1 Prophylactic and/or therapeutic agent for anemia comprising tetrahydroquinoline compound as active ingredient
10/07/2010WO2010113151A1 Conjugated antimicrobial agents
10/07/2010WO2010112222A1 Progressive emulsion crystallization
10/07/2010WO2010062506A3 Decahydro-1h-indenoquinolinone and decahydro-3h-cyclopentaphenanthridinone cyp17 inhibitors
10/07/2010US20100256377 Aluminum chelate complex for organic el material
10/07/2010US20100256201 Cell differentiation inducer
10/07/2010US20100256183 Fungicidal 2-alkylthio-2-quinolinyloxy-acetamide derivatives
10/07/2010US20100256113 Quinolone derivative
10/07/2010US20100255992 Soluble Liquid Formulations of Quinclorac Ammonium Salts
10/06/2010EP2235014A2 Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof
10/06/2010EP2234980A1 Fused cynopryridines and the use thereof
10/06/2010CN101855201A Oxime esters and photopolymerization initiators containing the same
10/06/2010CN101851198A Preparation method of ciprofloxacin hydrochloride
10/06/2010CN101851197A Method for synthesizing and refining quinclorac
10/06/2010CN101851196A 2-(1H) quinolinone derivative, medical composition, preparation method and application thereof
10/06/2010CN101851195A Quinoline compound and synthetic method and application thereof in synthesizing camptothecin alkaloid
10/06/2010CN101851173A Inhibitors of histone deacetylase
10/06/2010CN101849953A Inflammatory cytokine release inhibitor
10/06/2010CN101323589B Preparation of novel compound and montelukast sodium
10/05/2010US7807694 Amine substituted (dihydro- or tetrahydro-)quinoline, pyranopyridine, thiapyranopyridine, or naphthyridine derivatives as chemokine receptor modulators; lymphadenopathy associated, human T-cell leukemia/lymphoma, and/or feline immunodeficiency virus infections
10/05/2010US7807692 peroxisome proliferator activated receptor agonists useful in the treatment and control of hyperglycemia that is symptomatic of non-insulin dependent diabetes, as well as dyslipidemia, hyperlipidemia, hypercholesterolemia, hypertriglyceridemia and obesity that are often associated with type II diabetes
09/2010
09/30/2010WO2010111303A2 Imaging agents for detecting neurological disorders
09/30/2010WO2010110199A1 Curable coloring composition, color filter and method for producing same, and quinophthalone dye
09/30/2010WO2010108902A1 1,1,1-trifluoro-2-hydroxypropyl compounds
09/30/2010US20100249262 Oxime ester compound and photopolymerization initiator containing the same
09/30/2010US20100249182 Aminoquinoline derivatives, preparation method thereof and pharmaceutical composition comprising the same
09/30/2010US20100249139 1,1,1-trifluoro-2-hydroxypropyl compounds
09/30/2010US20100249124 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
09/30/2010US20100249024 Cetp inhibitors
09/30/2010US20100248313 Novel optically active, heteroaromatic beta-hydroxy esters and processes for their preparation from beta-keto esters and processes for the preparation of these beta-keto esters
09/30/2010US20100248264 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
09/30/2010CA2756137A1 Imaging agents for detecting neurological disorders
09/30/2010CA2754184A1 1,1,1-trifluoro-2-hydroxypropyl compounds
09/29/2010EP2233471A1 A salt of 7-{4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy}-3,4.dihydro-2(1h)-quinolinone with 5-sulfosalicylic acid and its preparation process
09/29/2010EP2233459A1 Method for producing conjugated aromatic compound
09/29/2010EP2231614A2 Quinoline derivatives and their use as fungicides
09/29/2010EP2231613A1 Montelukast benzhydryl piperazine salts and process for preparation thereof
09/29/2010EP1638928B1 N-alkynyl-2-(substituted aryloxy)alkylthioamide derivatives as fungicides
09/29/2010EP1534695B1 Tyrosine kinase inhibitors
09/29/2010CN1821217B Process for producing trans-4-amino-1-cyclohexanecarboxylic acid derivative
09/29/2010CN101848895A Combination of anti-angiogenic substance and anti-tumor platinum complex
09/29/2010CN101847479A Microwave composite material and preparation method thereof
09/29/2010CN101845016A Method for synthesizing derivatives of chiral tetrahydroquinoline by catalyzing asymmetric hydrosilylation with iridium
09/29/2010CN101337931B Crystal of salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)amino-phenoxy)-7-methoxy-6-quinolinecarboxamide or of solvate thereof and processes for producing these
09/29/2010CN101006076B Modulators of ATP-binding cassette transporters
09/28/2010US7803791 biological conjugate drug comprising enzyme inhibitor antibiotics and protein, for the treatment and/or prophylaxis of bacterial inflammatory processes, solid tumor; norfloxacin with albumin; antiinflammatory agents, antitumor agents
09/28/2010CA2395772C Sulfonamide-containing heterocyclic compounds
09/28/2010CA2387016C Acrylamide derivatives as fab i inhibitors
09/28/2010CA2386417C Phenyl- and pyridyl-tetrahydropyridines having tnf-inhibiting activity
09/23/2010WO2010108162A1 Process for making modulators of cystic fibrosis transmembrane conductance regulator
09/23/2010WO2010108155A1 Modulators of cystic fibrosis transmembrane conductance regulator
09/23/2010WO2010107768A1 Bicyclic compounds as inhibitors of diacylglycerol acyltransferase
09/23/2010WO2010107329A2 Aripiprazole salts
09/23/2010WO2010105761A1 A process for the preparation of 6-(7-((1-aminocyclopropyl)methoxy)-6-methoxyquinolin-4-yloxy)-n-methyl-1-naphthamide and synthetic intermediates thereof
09/23/2010WO2010059633A3 Compounds for treating parasitic disease
09/23/2010US20100240654 Hydrazide derivatives
09/23/2010US20100240649 Quinazoline and quinoline derivatives as irreversible protein tyrosine kinase inhibitors
09/23/2010US20100240639 Sulfonyl-Derivatives as Novel or Histone Deacetylase
09/23/2010US20100239678 Ionically functionalized nanodiamonds
09/23/2010US20100239496 Imaging agents for detecting neurological disorders
09/23/2010CA2756031A1 Process for making modulators of cystic fibrosis transmembrane conductance regulator
09/23/2010CA2755969A1 Modulators of cystic fibrosis transmembrane conductance regulator
09/23/2010CA2755253A1 Bicyclic compounds as inhibitors of diacylglycerol acyltransferase
09/22/2010EP1730135B1 Qiunolin-4-ones as inhibitors of retroviral integrase for the treatment of hiv, aids and aids related complex (arc)
09/22/2010CN101838237A Clean production process for separating 8-hydroxyquinoline from quinoline method neutralizing solution
09/21/2010US7799922 adenosine A3 receptor antagonists; improved bioavailability; treatment of diseases such as asthma, COPD and ARDS, glaucoma, tumor, allergic and inflammatory diseases, ischemia, hypoxia, arrythmia and renal diseases; e.g. 4-Methoxy-N-[6-(morpholin-4-yl)-4-benzylamino-3-cyanoquinolin-2-yl]-benzamide
09/21/2010US7799824 Quaternary salt CCR2 antagonists
09/21/2010US7799803 Hydroxamic acid compounds and methods of use thereof
09/21/2010US7799774 Quinoline derivatives and their use as 5-HT6 ligands
09/21/2010CA2436225C N-(arylsulphonyl)beta-amino acid derivatives comprising a substituted aminomethyl group, process for preparing them and pharmaceutical compositions containing them
09/21/2010CA2401502C Carboxylic acid derivatives as ip antagonists
09/16/2010WO2010102831A1 Process for manufacturing 5-(2-{[6-(2,2-difluoro-2-phenyiethoxy) hexyl]amino}-l- hydroxyethyl)-8-hydroxyquinolin-2(1h)-one.
09/16/2010WO2010102811A1 Substituted 2-mercaptoquinoline-3-carboxamides as kcnq2/3 modulators
09/16/2010WO2010102779A1 Substituted 3-amino-2-mercaptoquinolines as kcnq2/3 modulators
09/16/2010WO2010065865A3 Sulfonamide derivatives as bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
09/16/2010WO2009138712A3 Chemical compounds
09/16/2010US20100234424 Derivatives of n-phenyl(piperidine-2-yl) methyl benzamide preparation method thereof and applications of same in therapeutics
09/16/2010US20100234421 Substituted 3-amino-2-mercaptoquinolines as kcnq2/3 modulators
09/16/2010US20100234417 Thyrotropin releasing hormone receptor-orexin receptor hetero-dimers/-oligomers
09/16/2010US20100234409 Amino cyclopentyl heterocyclic and carbocyclic modulators of chemokine receptor activity
09/16/2010US20100234373 Bis-aryl amide compounds and methods of use
09/16/2010US20100234350 Platelet adp receptor inhibitors
09/16/2010US20100234345 Novel compounds as cannabinoid receptor ligands
09/16/2010US20100233106 Small-molecule modulators of melanin expression
09/16/2010CA2755004A1 Substituted 2-mercaptoquinoline-3-carboxamides as kcnq2/3 modulators
09/16/2010CA2754943A1 Substituted 3-amino-2-mercaptoquinolines as kcnq2/3 modulators
09/16/2010CA2752246A1 Process for manufacturing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1- hydroxyethyl)-8-hydroxyquinolin-2(1h)-one
09/15/2010EP2228368A1 Process for manufacturing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one
09/15/2010CN101835743A Fungicidal compounds, method for the production thereof, and use thereof to combat damaging fungi, and agents comprising the same
09/15/2010CN101830921A Novel method for activating 7-halogen of fluoroquinoline-3carboxylic acid and application thereof in forming side chain with secondary amine by using condensation
09/15/2010CN101830848A Polyamine derivative as well as preparation method and application thereof
09/15/2010CN101829602A Catalytic system for preparing N-Boc-aromatic amine compounds and preparation method and application thereof
1 ... 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 ... 277